{"id":"W3005879958","doi":"10.1158/1538-7445.sabcs19-p1-19-06","title":"Abstract P1-19-06: Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2− advanced breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Letrozole; Tamoxifen; Anastrozole; Internal medicine; Breast cancer; Oncology; Population; Quality of life (healthcare); Cancer; Palbociclib; Metastatic breast cancer; Gynecology; Confidence interval; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002097825,0.0009371864,0.001100593,0.000366472,0.0003019728,0.0007669061,0.0007252583,0.0006352427,0.007134711],"category_scores_gemma":[0.001167136,0.0001843497,0.001887803,0.0004598461,0.0003904371,0.0004058468,0.0005951699,0.001947787,0.0007469606],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004529232,"about_ca_system_score_gemma":0.0007759125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005800261,"about_ca_topic_score_gemma":0.001906328,"domain_scores_codex":[0.9992313,0.0004156679,0.00005192245,0.0001032779,0.0001113076,0.00008650726],"domain_scores_gemma":[0.9989261,0.0002009749,0.000344674,0.00007332467,0.00008901737,0.0003658347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8601527,0.008067692,0.04366772,0.002656007,0.01046859,0.0001521677,0.0001064572,0.001311419,0.006537832,0.0002263524,0.01296795,0.05368507],"study_design_scores_gemma":[0.4611235,0.1663787,0.3383363,0.0003171454,0.01198929,0.0004936514,0.0001332718,0.0016894,0.003566794,0.000518789,0.01535008,0.0001031535],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9583837,0.00991516,0.0004054076,0.001139739,0.0002480718,0.001476779,0.02151744,0.00006147761,0.006852234],"genre_scores_gemma":[0.9678463,0.001863665,0.0005675662,0.001048588,0.0003994984,0.002293782,0.02178085,0.00001675841,0.004182966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007134711,"threshold_uncertainty_score":0.02386796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09963595940985603,"score_gpt":0.3993271814967906,"score_spread":0.2996912220869346,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}